Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study [Phase 2]

View source ↗

Summary

This Phase 2 RSV viral challenge trial update reports safety, efficacy and pharmacokinetics data for BTA-C585.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• BTA-C585

Snippet

Sponsor: Biota Pharma Europe Limited | Conditions: Respiratory Syncytial Virus (RSV) Infection | Phase 2 | Status: COMPLETED